Bolus dose response characteristics of single chain urokinase plasminogen activator and tissue plasminogen activator in a dog model of arterial thrombosis-Reference-Cited by-同舟云学术

Bolus dose response characteristics of single chain urokinase plasminogen activator and tissue plasminogen activator in a dog model of arterial thrombosis

Published:1988-11 Issue:4 Volume:52 Page:295-312
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Badylak S.F.,Voytik S.,Klabunde R.E.,Henkin J.,Leski M.

Publisher

Elsevier BV

Subject

Hematology

Reference35 articles.

1. Tissue plasminogen activator: an evaluation of clinical efficacy in acute myocardial infarction;Rogers;Pharmacotherapy,1987

2. Tissue-type plasminogen activator;Lijnen;Ann. Biol. Clin.,1987

3. Kinetics of the activation of plasminogen by human tissue plasminogen activator;Hoylaerts,1982

4. Pharmacology of thrombolytic drugs;Verstraete;J. Am. Coll. Cardiol.,1986

5. Human tissue type plasminogen activator (rt-PA); from the laboratory to the bedside;Collen;Circulation,1985

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 6: Defining rational use of thrombolytics;Journal of Veterinary Emergency and Critical Care;2022-07

2. Use of tissue plasminogen activator to alleviate postoperative subcutaneous ureteral bypass obstruction secondary to blood clot in seven cats;Journal of Feline Medicine and Surgery;2021-02-05

3. Thrombolysis vs. bleeding from hemostatic sites by a prourokinase mutant compared with tissue plasminogen activator;Journal of Thrombosis and Haemostasis;2006-07

4. Thrombolytic Therapy in Dogs and Cats;Journal of Veterinary Emergency and Critical Care;2001-06

5. Urokinase and Single-Chain Urokinase-Type Plasminogen Activator (Pro-urokinase);Handbook of Experimental Pharmacology;2001